News

The global RNA therapeutics and vaccines market is projected to reach USD 940 million by 2035, growing at a CAGR of 68%. This ...
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
A new study by researchers at Bar-Ilan University has uncovered that certain ocean viruses—specifically RNA viruses—may ...
Guoping Li, Ph.D., of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the ...
DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...
Once injected into the bloodstream, the antibody TMAB3, combined with a type of RNA that stimulates an innate immune reaction ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
Linked to neurological disorders, repeat RNAs aggregate inside droplets but can be disassembled with an engineered piece of ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
Once dismissed as “junk,” a group of RNA molecules has been found to help regrow damaged nerves in mice in new research. The ...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader ...
Scientists have created an artificial RNA system that can copy itself using simple building blocks and temperature changes.